Factors associated with genetic counseling for hereditary breast and ovarian cancer

Abstract

Patients suspected of hereditary breast and ovarian cancer (HBOC) are referred to the Clinical Genetics Unit from the department of Obstetrics and Gynecology and department of Surgery, of our institution. Pre-counseling is initially provided, after which genetic counseling is provided to those who request it. However, there are patients who do not desire genetic counseling even among those at high risk for HBOC. The purpose of the present study was to clarify the background factors associated with genetic counseling for HBOC by comparing those who received genetic counseling with those who did not. Patients undergoing preoperative or postoperative adjuvant chemotherapy often did not receive genetic counseling. Pre-treatment patients and those receiving treatment were considered to lack the time, financial resources, or mental strength to undergo such counseling. Observing treatment progress, and repeating guidance on genetic counseling, may be effective to increase the number of the patients who undergo such counseling.